Harrow Inc (NASDAQ: HROW) on Tuesday, plunged -3.85% from the previous trading day, before settling in for the closing price of $23.09. Within the past 52 weeks, HROW’s price has moved between $9.86 and $59.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 33.27% over the past five years. The company achieved an average annual earnings per share of 200.00%. With a float of $30.80 million, this company’s outstanding shares have now reached $35.62 million.
Let’s look at the performance matrix of the company that is accounted for 382 employees. In terms of profitability, gross margin is 75.33%, operating margin of 4.42%, and the pretax margin is -8.16%.
Harrow Inc (HROW) Insider Updates
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Harrow Inc is 13.63%, while institutional ownership is 58.48%. The most recent insider transaction that took place on Mar 18 ’25, was worth 150,055. In this transaction 10% Owner of this company sold 5,000 shares at a rate of $30.01, taking the stock ownership to the 140,000 shares. Before that another transaction happened on Mar 18 ’25, when Company’s 10% Owner sold 5,000 for $29.64, making the entire transaction worth $148,200. This insider now owns 145,000 shares in total.
Harrow Inc (HROW) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 200.00% per share during the next fiscal year.
Harrow Inc (NASDAQ: HROW) Trading Performance Indicators
Harrow Inc (HROW) is currently performing well based on its current performance indicators. A quick ratio of 1.96 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.49, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 1.70 in one year’s time.
Technical Analysis of Harrow Inc (HROW)
Harrow Inc (NASDAQ: HROW) saw its 5-day average volume 0.63 million, a positive change from its year-to-date volume of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 12.15%. Additionally, its Average True Range was 2.36.
During the past 100 days, Harrow Inc’s (HROW) raw stochastic average was set at 3.21%, which indicates a significant decrease from 7.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.32% in the past 14 days, which was lower than the 68.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.63, while its 200-day Moving Average is $35.32. Nevertheless, the first resistance level for the watch stands at $24.52 in the near term. At $26.83, the stock is likely to face the second major resistance level. The third major resistance level sits at $28.23. If the price goes on to break the first support level at $20.81, it is likely to go to the next support level at $19.41. Assuming the price breaks the second support level, the third support level stands at $17.10.
Harrow Inc (NASDAQ: HROW) Key Stats
Market capitalization of the company is 791.52 million based on 35,654K outstanding shares. Right now, sales total 199,610 K and income totals -17,480 K. The company made 66,830 K in profit during its latest quarter, and 6,780 K in sales during its previous quarter.
